Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

February 14, 2016 1:25 PM ET

Personal Products

Company Overview of SkinMedica, Inc.

Company Overview

SkinMedica, Inc. develops and markets skin care products that rejuvenate skin. The company offers acne treatment products, age defense products, brighteners, cleansers and toners, glycolics, moisturizers, peels, redness relief products, retinols, scar recovery solutions, sunscreens, and systems and kits. It sells its products through physicians' offices in the United States, as well as through its online store. The company was founded in 1999 and is based in Carlsbad, California. As of December 19, 2012, SkinMedica, Inc. operates as a subsidiary of Allergan, Inc.

5909 Sea Lion Place

Suite H

Carlsbad, CA 92010

United States

Founded in 1999

110 Employees





Key Executives for SkinMedica, Inc.

Chief Executive Officer and Director
Age: 53
Age: 52
Chairman and Member of Compensation Committee
Age: 66
Co-Founder, Chairman of Scientific Advisory Board and Director
Age: 70
Compensation as of Fiscal Year 2015.

SkinMedica, Inc. Key Developments

Consumers Files Proposed Class-Action Lawsuit Against Allergan Inc. and SkinMedica

Consumers filed a proposed class-action lawsuit against Allergan Inc. and its subsidiary, SkinMedica, claiming that the companies have misbranded and unlawfully marketed Tissue Nutrient Solution (TNS), a skin-care product line containing human growth factors obtained from human foreskin tissue which could increase the risk of cancer and pose other health risks. The lawsuit, filed by consumer-rights law firm Hagens Berman in the U.S. District Court for the Central District of California, claims that for at least the past four years, SkinMedica has failed to disclose significant safety concerns associated with TNS products while marketing the products without appropriate government approval, proper labeling, or adequate safety studies. The suit alleges that in marketing their TNS products, Allergan and its subsidiary SkinMedica did not adequately disclose the health risks associated with these growth factors. The lawsuit is a proposed class action based upon California's consumer protection laws, and seeks to represent a class of all persons in the U.S. who purchased SkinMedica's TNS products during the last four years.

Similar Private Companies By Industry

Company Name Region
VitaQuest International, Inc. United States
Fashion Fair, LLC United States
Niadyne, Incorporated United States
Barbasol, LLC United States
Robertet Fragrances, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact SkinMedica, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at